Login / Signup

Cerebrospinal fluid metabolic markers predict prognosis behavior of primary central nervous system lymphoma with high-dose methotrexate-based chemotherapeutic treatment.

Liying ZhouQing LiJingshen XuShuaikang WangZhiqiang SongXinyi ChenYan MaZhiguang LinBobin ChenHe Huang
Published in: Neuro-oncology advances (2022)
We developed a logical regression model based on metabolic markers in CSF that can effectively predict PCNSL patient prognosis before the HD-MTX-based chemotherapy treatments.
Keyphrases
  • cerebrospinal fluid
  • high dose
  • low dose
  • stem cell transplantation
  • diffuse large b cell lymphoma
  • case report
  • locally advanced
  • squamous cell carcinoma
  • combination therapy
  • radiation therapy